The study described here investigated the anti-obesity effects of S. miltiorrhiza components and ST32db, a novel modified liposoluble compound from S. miltiorrhiza components, on mice with HFD-induced obesity and explored the corresponding molecular mechanism, which occurs via the ATF3-mediated signaling pathway. This evidence concerns the gene ATF3 and obesity disorder.